Qyuns Therapeutics (HKG:2509) said it invested 100 million yuan in a wealth management product offered by Shanghai Pudong Development Bank, according to a Hong Kong bourse filing Monday.
Shares of the biopharmaceutical company gained over 3% in afternoon trade Tuesday.
The product matures Sept. 23 and offers a guaranteed yield of 0.95% and a floating yield of 0% or 1.05% in the mid range or 1.25% in the high range.